AI Reckoning Ep 1: The Reckoning — 5% of Pharma Has AI Advantage, 95% Still Running Pilots

Only 5% of pharma companies have turned AI into competitive advantage. 89% of AI pilots fail to scale. The gap is widening, not closing. We unpack the $6.6B market reality, what "production scale" actually means vs. what companies claim, why 80% of AI transformation is organizational change not technology, the skills half-life crisis (2-5 years by 2030), and the board governance vacuum. Episode 1 of our 4-part special series "The AI Reckoning: Pharma's Make-or-Break Moment."